We have to keep in mind they have to be really careful. They know we want to dissect their every word and will try to interpret everything they say. That ‘s the problem, because they are forbidden to give too much away at this stage.  If they are careless, they could cause big problems for themselves. Even a qualitative comment about forthcoming results being « exciting » or « disappointing » , for example, could be too much. So, much of the vagueness and ambiguity is probably intentional.

In my view, the company has done a pretty good job over the years. It’s been a long hard slog and they have kept at it, conducted the trials well, and now  (let’s hope!!) may be on the verge of a medical breakthrough.